| Unichem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506690 |
NSE Symbol : UNICHEMLAB |
P/E(TTM) : 35.01 |
|
ISIN Demat : INE351A01035 |
Div & Yield% : 0.00 |
EPS(TTM) : 11.93 |
|
Book Value(₹) : 344.14 |
Market Cap(₹Cr) : 2,940.50 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 356.90 | 384.25 | 461.24 | 447.83 | 436.88 | 389.75 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 356.90 | 384.25 | 461.24 | 447.83 | 436.88 | 389.75 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 21.40 | 4.25 | 10.05 | 18.93 | 7.08 | 8.77 |
| Total Income | 378.30 | 388.50 | 471.29 | 466.76 | 443.96 | 398.52 |
| Total Expenditure | 382.34 | 358.51 | 386.26 | 373.62 | 372.38 | 349.56 |
| PBIDT | -4.04 | 29.99 | 85.03 | 93.14 | 71.58 | 48.96 |
| Interest | 3.68 | 1.93 | 1.53 | 2.89 | 1.82 | 1.38 |
| PBDT | -7.72 | 28.06 | 83.50 | 90.25 | 69.76 | 47.58 |
| Depreciation | 30.11 | 29.93 | 27.47 | 28.45 | 26.39 | 26.10 |
| Tax | 0.00 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.10 | -0.46 | 4.81 | 14.91 | 0.00 | 0.00 |
| Reported Profit After Tax | -39.93 | -1.85 | 51.22 | 46.89 | 43.37 | 21.48 |
| Extra-ordinary Items | -31.30 | 0.00 | 3.66 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -8.63 | -1.85 | 47.56 | 46.89 | 43.37 | 21.48 |
| EPS (Unit Curr.) | -5.67 | -0.26 | 7.28 | 6.66 | 6.16 | 3.05 |
| EPS (Adj) (Unit Curr.) | -5.67 | -0.26 | 7.28 | 6.66 | 6.16 | 3.05 |
| Calculated EPS (Unit Curr.) | -5.67 | -0.26 | 7.28 | 6.66 | 6.16 | 3.05 |
| Calculated EPS (Adj) (Unit Curr.) | -5.67 | -0.26 | 7.28 | 6.66 | 6.16 | 3.05 |
| Calculated EPS (Ann.) (Unit Curr.) | -22.69 | -1.05 | 29.10 | 26.64 | 24.64 | 12.20 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -22.69 | -1.05 | 29.10 | 26.64 | 24.64 | 12.20 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -1.13 | 7.80 | 18.44 | 20.80 | 16.38 | 12.56 |
| PBDTM(%) | -2.16 | 7.30 | 18.10 | 20.15 | 15.97 | 12.21 |
| PATM(%) | -11.19 | -0.48 | 11.10 | 10.47 | 9.93 | 5.51 |